Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Barnes

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Clinical Gastroenterology|August 1, 1989
Hemorrhagic ascites secondary to endometriosisW H Taub, S Rosado, M Kalaycioglu, et al.
Nutrition and Cancer|January 1, 1983
Effects of wheat, rice, corn, and soybean bran on 1,2-dimethylhydrazine-induced large bowel tumorigenesis in F344 ratsD S Barnes, N K Clapp, D A Scott, et al.
Gastrointestinal Endoscopy|October 1, 1995
A prospective, double-blind trial of somatostatin analog (octreotide) versus glucagon for the inhibition of small intestinal motility during endoscopic retrograde cholangiopancreatographyJ Van Dam, M F Catalano, D R Ferguson, et al.
Cleveland Clinic Journal of Medicine|November 1, 1993
Management of variceal bleeding in the 1990sJ M Henderson, W D Carey, D P Vogt, et al.
Alimentary Pharmacology & Therapeutics|November 18, 2003
The utility of the 13C-galactose breath test as a measure of liver functionS Saadeh, P W Behrens, M A Parsi, et al.
The American Journal of Gastroenterology|June 11, 1999
Immunogenicity of hepatitis A vaccine in decompensated liver diseaseJ A Dumot, D S Barnes, Z Younossi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 29, 2001
Listeria monocytogenes tricuspid valve endocarditis with septic pulmonary emboli in a liver transplant recipientR K Avery, D S Barnes, J C Teran, et al.
Journal of Hepatology|February 24, 2001
A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapyZ M Younossi, K D Mullen, W Zakko, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Outcome of de novo hepatitis C virus infection in heart transplant recipientsJ P Ong, D S Barnes, Z M Younossi, et al.
Transplantation|March 27, 1995
The prevalence of coronary artery disease in liver transplant candidates over age 50W D Carey, J A Dumot, R R Pimentel, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Gastroenterology|August 1, 1989
Hemorrhagic ascites secondary to endometriosisW H Taub, S Rosado, M Kalaycioglu, et al.
Nutrition and Cancer|January 1, 1983
Effects of wheat, rice, corn, and soybean bran on 1,2-dimethylhydrazine-induced large bowel tumorigenesis in F344 ratsD S Barnes, N K Clapp, D A Scott, et al.
Gastrointestinal Endoscopy|October 1, 1995
A prospective, double-blind trial of somatostatin analog (octreotide) versus glucagon for the inhibition of small intestinal motility during endoscopic retrograde cholangiopancreatographyJ Van Dam, M F Catalano, D R Ferguson, et al.
Cleveland Clinic Journal of Medicine|November 1, 1993
Management of variceal bleeding in the 1990sJ M Henderson, W D Carey, D P Vogt, et al.
Alimentary Pharmacology & Therapeutics|November 18, 2003
The utility of the 13C-galactose breath test as a measure of liver functionS Saadeh, P W Behrens, M A Parsi, et al.
The American Journal of Gastroenterology|June 11, 1999
Immunogenicity of hepatitis A vaccine in decompensated liver diseaseJ A Dumot, D S Barnes, Z Younossi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 29, 2001
Listeria monocytogenes tricuspid valve endocarditis with septic pulmonary emboli in a liver transplant recipientR K Avery, D S Barnes, J C Teran, et al.
Journal of Hepatology|February 24, 2001
A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapyZ M Younossi, K D Mullen, W Zakko, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Outcome of de novo hepatitis C virus infection in heart transplant recipientsJ P Ong, D S Barnes, Z M Younossi, et al.
Transplantation|March 27, 1995
The prevalence of coronary artery disease in liver transplant candidates over age 50W D Carey, J A Dumot, R R Pimentel, et al.
Pageof 3